Celularity Inc

Ownership Transactions Reported by 28 Insiders

Symbol
CELU, CELUW on Nasdaq
Location
170 Park Ave, Florham Park, NJ

There are no Buy or Sell transactions made by insiders since 2/1/2024

Celularity Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lim Kok Thay 10%+ Owner $13.1M Jan 24, 2025
Robert J. Hariri Chief Executive Officer $11.7M Apr 13, 2024
Dragasac Ltd 10%+ Owner $7.49M Jul 16, 2021
Peter Diamandis Director $5.65M Dec 19, 2024
Starr International Co Inc 10%+ Owner $3.81M Mar 1, 2022
Sorrento Therapeutics, Inc. 10%+ Owner $1.26M Sep 29, 2023
Dean C. Kehler Director $1.25M Dec 19, 2024
Diane L. Parks Director $1.25M Dec 19, 2024
Adrian Kilcoyne Chief Medical Officer $487K Feb 16, 2024
Genting Berhad 10%+ Owner $375K Jun 20, 2023
Richard J. Berman Director $277K Dec 19, 2024
Geoffrey M.D. Ling Director $277K Dec 19, 2024
John Sculley Director $250K Jun 14, 2023
John R. Haines Senior EVP, Chief Administrative Officer $158K Apr 13, 2024
David C. Beers Chief Financial Officer $98.6K Apr 13, 2024
Bradley Glover Executive Vice President, Chief Operating Officer $87.4K Apr 13, 2023
Kyle Fletcher Executive Vice President, General Counsel $86.7K Apr 13, 2024
Andrew Von Eschenbach Director $83.7K Jun 14, 2023
Stephen Brigido Pres, Functional Regeneration $80K Apr 13, 2024
Marc Mazur Director $58.8K Jun 14, 2023
Robin L. Smith Director $58.8K Jun 14, 2023
GX Sponsor LLC 10%+ Owner $24.9K Jul 16, 2021
Anne Jones Chief Business Officer $12.2K Jul 13, 2022
Keary Dunn General Counsel & Executive Vice President $4.09K Apr 13, 2022
Resorts World Inc Pte. Ltd. 10%+ Owner Jul 15, 2024
Beloo Mirakhur EVP, Clinical Development Sep 13, 2021
Andrew L. Pecora President Sep 15, 2021
Jay R. Bloom Director Sep 9, 2021

Recent Insider Transactions by Companies or Individuals for Celularity Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.